Exelixis Inc. (NASDAQ: EXEL) is a leading biotech company specializing in the discovery, development, and commercialization of cancer treatments. As the biotech sector experiences increased
In Tuesday’s premarket session, shares of Exela Technologies Inc. (XELA) were trading at $2.82, up 14.63%. At the close of the last trading session, Exela
XELA Technologies Inc. (XELA) shares fell -15.50% to $2.78 in premarket trading. Last trading session, Exela stock gained 22.76% to $3.29. There were 328.21 million
Exela Technologies Inc. (XELA) is in the red today in the premarket session, falling -1.26% to $2.36 at the last check. XELA stock rose 2.14%
Velodyne Lidar Inc. (VLDR) stock soared 7.5% to $26.53 in the pre-market trading after reporting that it has joined the Qualcomm® Smart Cities Accelerator Program
Mereo BioPharma Group plc (MREO) stock plunged -7.78% to $3.32 in the pre-market trading after declaring collaboration and license agreement with Ultragenyx Pharmaceutical Inc. (RARE),
Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.